Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Twist Bioscience Corp
(NQ:
TWST
)
53.00
+0.17 (+0.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Twist Bioscience Corp
< Previous
1
2
3
4
5
6
7
8
Next >
Twist Bioscience Announces Participation in SRC-SIA Webinar on the Decadal Plan for Semiconductors
November 30, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Upcoming Virtual Conferences
November 24, 2021
From
Twist Bioscience
Via
Business Wire
Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results
November 22, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities
November 22, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Expands Partnership with Invetx to Include Discovery of Best-in-Class Antibodies to Treat Multiple Diseases in Cats and Dogs
November 18, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases
November 15, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference
November 09, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Named in Inc.’s First Annual Best-Led Companies List
November 02, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2021 Fourth Quarter and Full Year Financial Results on Monday, November 22, 2021
November 01, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Exome 2.0 for Genomics Research
October 20, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and the Broad Institute Create Custom Whole Exome Target Enrichment Panel for Clinical Research
October 13, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Appoints Steffen Hellmold as Senior Vice President, Business Development, Data Storage
October 12, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
October 06, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Expands Expert Custom Alliance Panel Offering
October 05, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation
September 29, 2021
SOURCE: Illumina
Via
3BL Media
Twist Bioscience Appoints Dennis Cho as Senior Vice President, General Counsel and Chief Ethics and Compliance Officer
September 27, 2021
From
Twist Bioscience
Via
Business Wire
Twist Bioscience Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding to Multiple Strains of SARS-CoV-2, Including Alpha, Beta, and Gamma Strains, in Preclinical Studies
September 23, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Collaborates with Deep Learning Experts deepCDR on Antibody Library Design
September 23, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19
September 14, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
September 13, 2021
From
Twist Bioscience Corporation and Adicet Bio
Via
Business Wire
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
September 09, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Baird 2021 Global Healthcare Conference
September 08, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
August 10, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results
August 06, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors
August 06, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
July 26, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests
July 22, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021
July 21, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Acquires NGS Library Preparation Maker iGenomX
June 30, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening
June 14, 2021
From
Twist Bioscience Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.